Professor Amin Rostami Lecture - Virtual Clinical Studies: What Does It Mean and Why Do I Need to Know About Them?
- 18 November 2019 at 11:00 am – 12:00 pm
About Professor Amin Rostami
Professor Rostami is the Senior Vice President of Research & Development and Chief Scientific Officer at Certara. His mission is to insure that the latest scientific advances in the field of biosimulation are incorporated into all of the drug development efforts by various pharmaceutical companies.
He joined Certara in 2012 as a co-founder of Simcyp Limited. Amin is also a Professor of Systems Pharmacology and the Director of the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester. He has an active program of training PhD students involving proteomics, physiologically-based pharmacokinetics and pharmacodynamics, and precision dosing within
CAPKR, and numerous graduates from his team are currently active in pharmaceutical industry or academic research.
Professor Rostami was the first full Professor appointed with the title of Systems Pharmacology in 2007 whilst working at the University of Sheffield, He has authored/co-authored over 250 highly cited articles (>12,500 citations, H-Factor >55). In 2017, he
was listed by ISI as one of the world’s most highly cited researchers (under ‘Pharmacology &Toxicology’). He was a founding editor of Pharmacometrics and System Pharmacology and has served on the Editorial Boards of several other journals.
Professor Rostami is renowned for his contribution to translational modelling and has been an invited speaker at over 200 international and national meetings, in addition to leading numerous workshops in the area of IVIVE- PBPK linked models.
Date: Monday, 18 November 2019
Venue: Lecture Theatre 1, Sissons Building
Faculty of Pharmacy and Pharmaceutical Sciences
381 Royal Parade, Parkville